{"transactions":[{"id":3881310,"issuer":{"id":120602,"kind":"organization","name":"AVEO PHARMACEUTICALS, INC.","symbol":"AVEO"},"owners":[{"id":165402,"kind":"person","name":"Sakoda Jon","position":1,"cik":"0001589961","reported_name":"Sakoda Jon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-06-28T19:21:19.000Z","date":"2018-06-28","kind":"purchase","acquired":true,"shares":187130,"price":2.0985,"value":392692.305,"ownership":{"direct":false,"nature":"See Note 1"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.00 to $2.15, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Person is a manager of NEA 15 GP, LLC, (\"NEA 15 GP\") which is the sole general partner of NEA Partners 15, L.P. (\"NEA Partners 15\"). NEA Partners 15 is the sole general partner of New Enterprise Associates 15, L. P. (\"NEA 15\"). NEA 15 is the sole member of Growth Equity Opportunities Fund IV, LLC (\"GEO IV\"), which is the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares held by GEO IV in which the Reporting Person has no pecuniary interest."}],"balance_after":17783722,"source":{"system":"sec-edgar","filing":"0001209191-18-039966","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1325879/000120919118039966/doc4.xml","form_type":"4"}},{"id":3881309,"issuer":{"id":120602,"kind":"organization","name":"AVEO PHARMACEUTICALS, INC.","symbol":"AVEO"},"owners":[{"id":165402,"kind":"person","name":"Sakoda Jon","position":1,"cik":"0001589961","reported_name":"Sakoda Jon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-06-28T19:21:19.000Z","date":"2018-06-27","kind":"purchase","acquired":true,"shares":5295,"price":2.15,"value":11384.25,"ownership":{"direct":false,"nature":"See Note 1"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Person is a manager of NEA 15 GP, LLC, (\"NEA 15 GP\") which is the sole general partner of NEA Partners 15, L.P. (\"NEA Partners 15\"). NEA Partners 15 is the sole general partner of New Enterprise Associates 15, L. P. (\"NEA 15\"). NEA 15 is the sole member of Growth Equity Opportunities Fund IV, LLC (\"GEO IV\"), which is the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares held by GEO IV in which the Reporting Person has no pecuniary interest."}],"balance_after":17596592,"source":{"system":"sec-edgar","filing":"0001209191-18-039966","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1325879/000120919118039966/doc4.xml","form_type":"4"}},{"id":3914040,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":165402,"kind":"person","name":"Sakoda Jon","position":1,"cik":"0001589961","reported_name":"Sakoda Jon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-05-30T21:05:58.000Z","date":"2018-05-25","kind":"grant","acquired":true,"shares":416667,"price":4,"value":1666668.0,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a manager of NEA 15 GP which is the sole general partner of NEA Partners 15-OF, L.P. (\"NEA Partners 15-OF\"). NEA Partners 15-OF is the sole general partner of NEA 15 Opportunity Fund, L. P. (\"NEA Opportunity 15\"), the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA Opportunity 15 in which the Reporting Person has no pecuniary interest."}],"balance_after":3082186,"source":{"system":"sec-edgar","filing":"0001209191-18-034179","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1437402/000120919118034179/doc4.xml","form_type":"4"}},{"id":3914039,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":165402,"kind":"person","name":"Sakoda Jon","position":1,"cik":"0001589961","reported_name":"Sakoda Jon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-05-30T21:05:58.000Z","date":"2018-05-25","kind":"grant","acquired":true,"shares":416666,"price":4,"value":1666664.0,"ownership":{"direct":false,"nature":"See Note 1"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Person is a manager of NEA 15 GP, LLC, (\"NEA 15 GP\") which is the sole general partner of NEA Partners 15, L.P. (\"NEA Partners 15\"). NEA Partners 15 is the sole general partner of New Enterprise Associates 15, L. P. (\"NEA 15\"), the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 15 in which the Reporting Person has no pecuniary interest."}],"balance_after":3082186,"source":{"system":"sec-edgar","filing":"0001209191-18-034179","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437402/000120919118034179/doc4.xml","form_type":"4"}},{"id":3913952,"issuer":{"id":120602,"kind":"organization","name":"AVEO PHARMACEUTICALS, INC.","symbol":"AVEO"},"owners":[{"id":165402,"kind":"person","name":"Sakoda Jon","position":1,"cik":"0001589961","reported_name":"Sakoda Jon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-05-30T17:11:33.000Z","date":"2018-05-30","kind":"purchase","acquired":true,"shares":275,"price":2.15,"value":591.25,"ownership":{"direct":false,"nature":"See Note 1"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Person is a manager of NEA 15 GP, LLC, (\"NEA 15 GP\") which is the sole general partner of NEA Partners 15, L.P. (\"NEA Partners 15\"). NEA Partners 15 is the sole general partner of New Enterprise Associates 15, L. P. (\"NEA 15\"). NEA 15 is the sole member of Growth Equity Opportunities Fund IV, LLC (\"GEO IV\"), which is the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares held by GEO IV in which the Reporting Person has no pecuniary interest."}],"balance_after":17591297,"source":{"system":"sec-edgar","filing":"0001209191-18-034189","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1325879/000120919118034189/doc4.xml","form_type":"4"}},{"id":3923883,"issuer":{"id":120602,"kind":"organization","name":"AVEO PHARMACEUTICALS, INC.","symbol":"AVEO"},"owners":[{"id":165402,"kind":"person","name":"Sakoda Jon","position":1,"cik":"0001589961","reported_name":"Sakoda Jon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-05-21T17:26:17.000Z","date":"2018-05-21","kind":"purchase","acquired":true,"shares":32200,"price":2.1447,"value":69059.34,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.13 to $2.15, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (4) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a manager of NEA 15 GP, LLC, (\"NEA 15 GP\") which is the sole general partner of NEA Partners 15, L.P. (\"NEA Partners 15\"). NEA Partners 15 is the sole general partner of New Enterprise Associates 15, L. P. (\"NEA 15\"). NEA 15 is the sole member of Growth Equity Opportunities Fund IV, LLC (\"GEO IV\"), which is the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares held by GEO IV in which the Reporting Person has no pecuniary interest."}],"balance_after":17591022,"source":{"system":"sec-edgar","filing":"0001209191-18-031987","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1325879/000120919118031987/doc4.xml","form_type":"4"}},{"id":3923882,"issuer":{"id":120602,"kind":"organization","name":"AVEO PHARMACEUTICALS, INC.","symbol":"AVEO"},"owners":[{"id":165402,"kind":"person","name":"Sakoda Jon","position":1,"cik":"0001589961","reported_name":"Sakoda Jon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-05-21T17:26:17.000Z","date":"2018-05-18","kind":"purchase","acquired":true,"shares":20100,"price":2.1357,"value":42927.57,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.12 to $2.15, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (3) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a manager of NEA 15 GP, LLC, (\"NEA 15 GP\") which is the sole general partner of NEA Partners 15, L.P. (\"NEA Partners 15\"). NEA Partners 15 is the sole general partner of New Enterprise Associates 15, L. P. (\"NEA 15\"). NEA 15 is the sole member of Growth Equity Opportunities Fund IV, LLC (\"GEO IV\"), which is the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares held by GEO IV in which the Reporting Person has no pecuniary interest."}],"balance_after":17558822,"source":{"system":"sec-edgar","filing":"0001209191-18-031987","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1325879/000120919118031987/doc4.xml","form_type":"4"}},{"id":3923881,"issuer":{"id":120602,"kind":"organization","name":"AVEO PHARMACEUTICALS, INC.","symbol":"AVEO"},"owners":[{"id":165402,"kind":"person","name":"Sakoda Jon","position":1,"cik":"0001589961","reported_name":"Sakoda Jon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-05-21T17:26:17.000Z","date":"2018-05-17","kind":"purchase","acquired":true,"shares":184179,"price":2.1253,"value":391435.6287,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.095 to $2.15, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a manager of NEA 15 GP, LLC, (\"NEA 15 GP\") which is the sole general partner of NEA Partners 15, L.P. (\"NEA Partners 15\"). NEA Partners 15 is the sole general partner of New Enterprise Associates 15, L. P. (\"NEA 15\"). NEA 15 is the sole member of Growth Equity Opportunities Fund IV, LLC (\"GEO IV\"), which is the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares held by GEO IV in which the Reporting Person has no pecuniary interest."}],"balance_after":17538722,"source":{"system":"sec-edgar","filing":"0001209191-18-031987","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1325879/000120919118031987/doc4.xml","form_type":"4"}},{"id":3938727,"issuer":{"id":120602,"kind":"organization","name":"AVEO PHARMACEUTICALS, INC.","symbol":"AVEO"},"owners":[{"id":165402,"kind":"person","name":"Sakoda Jon","position":1,"cik":"0001589961","reported_name":"Sakoda Jon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-05-10T17:02:40.000Z","date":"2018-05-08","kind":"purchase","acquired":true,"shares":70873,"price":2.1341,"value":151250.0693,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.1101 to $2.15, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a manager of NEA 15 GP, LLC, (\"NEA 15 GP\") which is the sole general partner of NEA Partners 15, L.P. (\"NEA Partners 15\"). NEA Partners 15 is the sole general partner of New Enterprise Associates 15, L. P. (\"NEA 15\"). NEA 15 is the sole member of Growth Equity Opportunities Fund IV, LLC (\"GEO IV\"), which is the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares held by GEO IV in which the Reporting Person has no pecuniary interest."}],"balance_after":17354543,"source":{"system":"sec-edgar","filing":"0001209191-18-029302","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1325879/000120919118029302/doc4.xml","form_type":"4"}},{"id":3966088,"issuer":{"id":120602,"kind":"organization","name":"AVEO PHARMACEUTICALS, INC.","symbol":"AVEO"},"owners":[{"id":165402,"kind":"person","name":"Sakoda Jon","position":1,"cik":"0001589961","reported_name":"Sakoda Jon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-04-10T17:31:03.000Z","date":"2018-04-10","kind":"purchase","acquired":true,"shares":203200,"price":2.4606,"value":499993.92,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.385 to $2.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (4) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a manager of NEA 15 GP, LLC, (\"NEA 15 GP\") which is the sole general partner of NEA Partners 15, L.P. (\"NEA Partners 15\"). NEA Partners 15 is the sole general partner of New Enterprise Associates 15, L. P. (\"NEA 15\"). NEA 15 is the sole member of Growth Equity Opportunities Fund IV, LLC (\"GEO IV\"), which is the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares held by GEO IV in which the Reporting Person has no pecuniary interest."}],"balance_after":17283670,"source":{"system":"sec-edgar","filing":"0001209191-18-024539","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1325879/000120919118024539/doc4.xml","form_type":"4"}},{"id":3966087,"issuer":{"id":120602,"kind":"organization","name":"AVEO PHARMACEUTICALS, INC.","symbol":"AVEO"},"owners":[{"id":165402,"kind":"person","name":"Sakoda Jon","position":1,"cik":"0001589961","reported_name":"Sakoda Jon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-04-10T17:31:03.000Z","date":"2018-04-09","kind":"purchase","acquired":true,"shares":32100,"price":2.433,"value":78099.3,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.325 to $2.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (3) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a manager of NEA 15 GP, LLC, (\"NEA 15 GP\") which is the sole general partner of NEA Partners 15, L.P. (\"NEA Partners 15\"). NEA Partners 15 is the sole general partner of New Enterprise Associates 15, L. P. (\"NEA 15\"). NEA 15 is the sole member of Growth Equity Opportunities Fund IV, LLC (\"GEO IV\"), which is the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares held by GEO IV in which the Reporting Person has no pecuniary interest."}],"balance_after":17080470,"source":{"system":"sec-edgar","filing":"0001209191-18-024539","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1325879/000120919118024539/doc4.xml","form_type":"4"}},{"id":3966086,"issuer":{"id":120602,"kind":"organization","name":"AVEO PHARMACEUTICALS, INC.","symbol":"AVEO"},"owners":[{"id":165402,"kind":"person","name":"Sakoda Jon","position":1,"cik":"0001589961","reported_name":"Sakoda Jon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-04-10T17:31:03.000Z","date":"2018-04-06","kind":"purchase","acquired":true,"shares":685676,"price":2.2415,"value":1536942.754,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.1001 to $2.38, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a manager of NEA 15 GP, LLC, (\"NEA 15 GP\") which is the sole general partner of NEA Partners 15, L.P. (\"NEA Partners 15\"). NEA Partners 15 is the sole general partner of New Enterprise Associates 15, L. P. (\"NEA 15\"). NEA 15 is the sole member of Growth Equity Opportunities Fund IV, LLC (\"GEO IV\"), which is the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares held by GEO IV in which the Reporting Person has no pecuniary interest."}],"balance_after":17048370,"source":{"system":"sec-edgar","filing":"0001209191-18-024539","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1325879/000120919118024539/doc4.xml","form_type":"4"}},{"id":3998172,"issuer":{"id":168341,"kind":"organization","name":"Cascadian Therapeutics, Inc.","symbol":"CASC"},"owners":[{"id":165402,"kind":"person","name":"Sakoda Jon","position":1,"cik":"0001589961","reported_name":"Sakoda Jon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-03-13T18:08:47.000Z","date":"2018-03-09","kind":"other","acquired":false,"shares":10882574,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares of Common Stock tendered in the tender offer launched by Valley Acquisition Sub, Inc. on February 8, 2018 pursuant to that certain Agreement and Plan of Merger, dated January 30, 2018, among Seattle Genetics, Inc., Valley Acquisition Sub, Inc., and Cascadian Therapeutics, Inc., to acquire all of the outstanding shares of common stock of Cascadian Therapeutics, Inc., par value $0.001 per share, at a purchase price of $10.00 per share, net to the seller in cash, without interest and less any required withholding taxes."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a manager of NEA 15 GP, LLC, (\"NEA 15 GP\") which is the sole general partner of NEA Partners 15, L.P. (\"NEA Partners 15\"). NEA Partners 15 is the sole general partner of New Enterprise Associates 15, L. P. (\"NEA 15\"). NEA 15 is the sole member of Growth Equity Opportunities Fund IV, LLC (\"GEO IV\"), which is the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares held by GEO IV in which the Reporting Person has no pecuniary interest."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-18-019375","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1412067/000120919118019375/doc4.xml","form_type":"4"}},{"id":4031656,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":165402,"kind":"person","name":"Sakoda Jon","position":1,"cik":"0001589961","reported_name":"Sakoda Jon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-02-27T21:37:39.000Z","date":"2018-02-26","kind":"sale","acquired":false,"shares":1460209,"price":0.5008,"value":731272.6672,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.475 to $0.625, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a manager of NEA 15 GP, LLC, (\"NEA 15 GP\") which is the sole general partner of NEA Partners 15, L.P. (\"NEA Partners 15\"). NEA Partners 15 is the sole general partner of New Enterprise Associates 15, L. P. (\"NEA 15\"). NEA 15 is the sole member of Growth Equity Opportunities Fund IV, LLC (\"GEO IV\"), which is the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares held by GEO IV in which the Reporting Person has no pecuniary interest."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-18-013937","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/907654/000120919118013937/doc4.xml","form_type":"4"}},{"id":4040141,"issuer":{"id":168341,"kind":"organization","name":"Cascadian Therapeutics, Inc.","symbol":"CASC"},"owners":[{"id":165402,"kind":"person","name":"Sakoda Jon","position":1,"cik":"0001589961","reported_name":"Sakoda Jon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series E Preferred Stock","published_at":"2018-02-22T16:44:28.000Z","date":"2018-02-20","kind":"exercise","acquired":false,"shares":1818000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Note 1"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each share of the Series E Preferred Stock is convertible into shares of the Issuer's Common Stock (subject to adjustment as provided in the\nrelated certificate of designation of preferences) at any time at the option of the holder, and has no expiration date, provided that the holder will\nbe prohibited from converting Series E Preferred Stock into shares of the Issuer's Common Stock if, as a result of such conversion, the holder,\ntogether with its affiliates, would own more than 19.99% of the total number of shares of the Issuer's Common Stock then issued and\noutstanding, which percentage may be changed at the holders' election to any other number less than or equal to 19.99% upon 61 days' notice\nto the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each share of the Series E Preferred Stock is convertible into shares of the Issuer's Common Stock (subject to adjustment as provided in the\nrelated certificate of designation of preferences) at any time at the option of the holder, and has no expiration date, provided that the holder will\nbe prohibited from converting Series E Preferred Stock into shares of the Issuer's Common Stock if, as a result of such conversion, the holder,\ntogether with its affiliates, would own more than 19.99% of the total number of shares of the Issuer's Common Stock then issued and\noutstanding, which percentage may be changed at the holders' election to any other number less than or equal to 19.99% upon 61 days' notice\nto the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Person is a manager of NEA 15 GP, LLC, (\"NEA 15 GP\") which is the sole general partner of NEA Partners 15, L.P. (\"NEA Partners 15\"). NEA Partners 15 is the sole general partner of New Enterprise Associates 15, L. P. (\"NEA 15\"). NEA 15 is the sole member of Growth Equity Opportunities Fund IV, LLC (\"GEO IV\"), which is the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares held by GEO IV in which the Reporting Person has no pecuniary interest."}],"balance_after":0,"derivative":{"exercise_price":3.3,"underlying":"Common Stock","underlying_shares":1818000},"source":{"system":"sec-edgar","filing":"0001209191-18-012478","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1412067/000120919118012478/doc4.xml","form_type":"4"}},{"id":4040140,"issuer":{"id":168341,"kind":"organization","name":"Cascadian Therapeutics, Inc.","symbol":"CASC"},"owners":[{"id":165402,"kind":"person","name":"Sakoda Jon","position":1,"cik":"0001589961","reported_name":"Sakoda Jon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-02-22T16:44:28.000Z","date":"2018-02-20","kind":"exercise","acquired":true,"shares":1818000,"price":3.3,"value":5999400.0,"ownership":{"direct":false,"nature":"See Note 1"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Person is a manager of NEA 15 GP, LLC, (\"NEA 15 GP\") which is the sole general partner of NEA Partners 15, L.P. (\"NEA Partners 15\"). NEA Partners 15 is the sole general partner of New Enterprise Associates 15, L. P. (\"NEA 15\"). NEA 15 is the sole member of Growth Equity Opportunities Fund IV, LLC (\"GEO IV\"), which is the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares held by GEO IV in which the Reporting Person has no pecuniary interest."}],"balance_after":10882574,"source":{"system":"sec-edgar","filing":"0001209191-18-012478","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1412067/000120919118012478/doc4.xml","form_type":"4"}},{"id":4369201,"issuer":{"id":120602,"kind":"organization","name":"AVEO PHARMACEUTICALS, INC.","symbol":"AVEO"},"owners":[{"id":165402,"kind":"person","name":"Sakoda Jon","position":1,"cik":"0001589961","reported_name":"Sakoda Jon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-03-29T16:11:52.000Z","date":"2017-03-28","kind":"purchase","acquired":true,"shares":6000000,"price":0.5,"value":3000000.0,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reports the purchase of shares in the underwritten public offering of common stock of AVEO Pharmaceuticals, Inc."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a manager of NEA 15 GP, LLC, (\"NEA 15 GP\") which is the sole general partner of NEA Partners 15, L.P. (\"NEA Partners 15\"). NEA Partners 15 is the sole general partner of New Enterprise Associates 15, L. P. (\"NEA 15\"). NEA 15 is the sole member of Growth Equity Opportunities Fund IV, LLC (\"GEO IV\"), which is the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares held by GEO IV in which the Reporting Person has no pecuniary interest."}],"balance_after":16362694,"source":{"system":"sec-edgar","filing":"0001209191-17-023492","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1325879/000120919117023492/doc4.xml","form_type":"4"}},{"id":4516885,"issuer":{"id":158957,"kind":"organization","name":"Achaogen, Inc.","symbol":"AKAO"},"owners":[{"id":165402,"kind":"person","name":"Sakoda Jon","position":1,"cik":"0001589961","reported_name":"Sakoda Jon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-12-19T16:46:41.000Z","date":"2016-12-19","kind":"purchase","acquired":true,"shares":500000,"price":13.5,"value":6750000.0,"ownership":{"direct":false,"nature":"See Note 1"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Person is a manager of NEA 15 GP, LLC, (\"NEA 15 GP\") which is the sole general partner of NEA Partners 15, L.P. (\"NEA Partners 15\"). NEA Partners 15 is the sole general partner of New Enterprise Associates 15, L. P. (\"NEA 15\"). NEA 15 is the sole member of Growth Equity Opportunities Fund IV, LLC (\"GEO IV\"), which is the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares held by GEO IV in which the Reporting Person has no pecuniary interest."}],"balance_after":5215128,"source":{"system":"sec-edgar","filing":"0001209191-16-155945","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1301501/000120919116155945/doc4.xml","form_type":"4"}}]}